Subscribe to Newsletter

Anthony Adamis

The Power List 2014


Anthony Adamis

Anthony Adamis has had two careers in ophthalmology: as a clinician and as an industry executive. One of the discoverers of the role that VEGF plays in retinal angiogenesis and leakage, Adamis also participated in the development and launch of pegaptanib, the first anti-VEGF agent for use in ophthalmology.


Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: